Akinola L, Bagdas D, Alkhlaif Y, Jackson A, Gurdap C, Rahimpour E
J Psychopharmacol. 2022; 36(11):1280-1293.
PMID: 36321267
DOI: 10.1177/02698811221132214.
Takata K, Kimura H, Yanagisawa D, Harada K, Nishimura K, Kitamura Y
Molecules. 2022; 27(9).
PMID: 35566132
PMC: 9102429.
DOI: 10.3390/molecules27092780.
Beaurain M, Salabert A, Ribeiro M, Arlicot N, Damier P, Le Jeune F
Front Med (Lausanne). 2019; 6:268.
PMID: 31828073
PMC: 6890558.
DOI: 10.3389/fmed.2019.00268.
Brody A, Hubert R, Mamoun M, Enoki R, Garcia L, Abraham P
Psychopharmacology (Berl). 2016; 233(17):3249-57.
PMID: 27370018
PMC: 4982797.
DOI: 10.1007/s00213-016-4367-x.
Ogunjirin A, Fortunak J, Brown L, Xiao Y, Davila-Garcia M
Neurochem Res. 2015; 40(10):2131-42.
PMID: 26508288
PMC: 4741274.
DOI: 10.1007/s11064-015-1705-z.
Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.
Gallezot J, Esterlis I, Bois F, Zheng M, Lin S, Kloczynski T
Synapse. 2014; 68(11):556-64.
PMID: 25043426
PMC: 4224280.
DOI: 10.1002/syn.21767.
Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.
Yu L, Zhang H, Caldarone B, Eaton J, Lukas R, Kozikowski A
J Med Chem. 2014; 57(20):8204-23.
PMID: 24901260
PMC: 4207546.
DOI: 10.1021/jm401937a.
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.
Simmons S, Gould T
J Clin Pharm Ther. 2014; 39(5):457-67.
PMID: 24828779
PMC: 4459499.
DOI: 10.1111/jcpt.12171.
Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.
Jasinska A, Zorick T, Brody A, Stein E
Neuropharmacology. 2013; 84:111-22.
PMID: 23474015
PMC: 3710300.
DOI: 10.1016/j.neuropharm.2013.02.015.
Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET.
Pichika R, Kuruvilla S, Patel N, Vu K, Sinha S, Easwaramoorthy B
Nucl Med Biol. 2012; 40(1):117-25.
PMID: 23141552
PMC: 3514651.
DOI: 10.1016/j.nucmedbio.2012.09.009.
Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers.
Lotfipour S, Mandelkern M, Brody A
Curr Med Imaging Rev. 2012; 7(2):107-112.
PMID: 22773924
PMC: 3389797.
DOI: 10.2174/157340511795445676.
Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity.
Yu L, Tuckmantel W, Eaton J, Caldarone B, Fedolak A, Hanania T
J Med Chem. 2011; 55(2):812-23.
PMID: 22148173
PMC: 3272775.
DOI: 10.1021/jm201301h.
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding.
Esterlis I, Cosgrove K, Batis J, Bois F, Stiklus S, Perkins E
J Nucl Med. 2010; 51(8):1226-33.
PMID: 20660383
PMC: 3707518.
DOI: 10.2967/jnumed.109.072447.
How much binding affinity can be gained by filling a cavity?.
Kawasaki Y, Chufan E, Lafont V, Hidaka K, Kiso Y, Amzel L
Chem Biol Drug Des. 2009; 75(2):143-51.
PMID: 20028396
PMC: 3209665.
DOI: 10.1111/j.1747-0285.2009.00921.x.
In vivo brain imaging of human exposure to nicotine and tobacco.
Sharma A, Brody A
Handb Exp Pharmacol. 2009; (192):145-71.
PMID: 19184649
PMC: 2893588.
DOI: 10.1007/978-3-540-69248-5_6.
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers.
Brasic J, Zhou Y, Musachio J, Hilton J, Fan H, Crabb A
Synapse. 2009; 63(4):339-58.
PMID: 19140167
PMC: 2766259.
DOI: 10.1002/syn.20611.
Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.
Brody A, Mandelkern M, Costello M, Abrams A, Scheibal D, Farahi J
Int J Neuropsychopharmacol. 2008; 12(3):305-16.
PMID: 18706128
PMC: 2773668.
DOI: 10.1017/S146114570800922X.
Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice.
Wildeboer K, Stevens K
Brain Res. 2008; 1224:29-36.
PMID: 18582447
PMC: 2596929.
DOI: 10.1016/j.brainres.2008.06.007.
Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380.
Vaupel D, Stein E, Mukhin A
Neuroimage. 2006; 34(4):1352-62.
PMID: 17187994
PMC: 2023973.
DOI: 10.1016/j.neuroimage.2006.10.036.
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.
Brody A, Mandelkern M, London E, Olmstead R, Farahi J, Scheibal D
Arch Gen Psychiatry. 2006; 63(8):907-15.
PMID: 16894067
PMC: 2773659.
DOI: 10.1001/archpsyc.63.8.907.